The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Immunology Letters

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.imlet.2016.09.001PMID 27616043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

•  IL-1β siRNA adenovirus benefits liver regeneration by improving mesenchymal stem cells survival after acute liver failure.

  2016cited by this paper
• MicroRNA-125b-5p attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production by targeting inhibiting LACTB in THP-1 macrophages.

  2016cited by this paper
• Deleterious effect of salusin-β in paraventricular nucleus on sympathetic activity and blood pressure via NF-κB signaling in a rat model of obesity hypertension.

  2015cited by this paper
• Deciphering the crosstalk among IL-1 and IL-10 family cytokines in intestinal immunity.

  2015cited by this paper
• Cytokines pre-determined by genetic factors are involved in pathogenesis of Rheumatoid arthritis.

  2015cited by this paper
• Bi-specific antibodies with high antigen-binding affinity identified by flow cytometry.

  2015cited by this paper
• Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway.

  2015cited by this paper
• SND-117, a sinomenine bivalent alleviates type II collagen-induced arthritis in mice.

  2015cited by this paper
• Adalimumab Reduces Photoreceptor Cell Death in A Mouse Model of Retinal Degeneration

  2015cited by this paper
• Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets.

  2014cited by this paper
• Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.

  2014cited by this paper
• Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.

  2013cited by this paper
• Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.

  2013influential reference
• A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis.

  2012cited by this paper
• A Cytokine-Centric View of the Pathogenesis and Treatment of Autoimmune Arthritis

  2011cited by this paper
• Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.

  2011cited by this paper
• Inflammasome activation and IL-1β and IL-18 processing during infection.

  2011cited by this paper
• Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis

  2011cited by this paper
• Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.

  2010cited by this paper
• Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative

  2010cited by this paper
• The regulation of IL-10 production by immune cells

  2010cited by this paper
• Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

  2010cited by this paper
• Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?

  2010cited by this paper
• IL-17–Mediated Monocyte Migration Occurs Partially through CC Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Induction

  2010cited by this paper
• 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

  2010cited by this paper
• Nuclear Factor-&kgr;B Activation Contributes to Vascular Endothelial Dysfunction via Oxidative Stress in Overweight/Obese Middle-Aged and Older Humans

  2009cited by this paper
• Animal models of rheumatoid arthritis

  2009cited by this paper
• Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

  2009cited by this paper
• Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis.

  2009cited by this paper
• Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease

  2008cited by this paper
• Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

  2008cited by this paper
• Treatment with total alkaloids from Radix Linderae reduces inflammation and joint destruction in type II collagen-induced model for rheumatoid arthritis.

  2007cited by this paper
• Collagen-induced arthritis

  2007cited by this paper
• Cytokines in the pathogenesis of rheumatoid arthritis

  2007cited by this paper
• Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases.

  2006cited by this paper
• A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.

  2006cited by this paper
• Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases

  2006cited by this paper
• Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

  2004cited by this paper
• Interleukin-10 and related cytokines and receptors.

  2004cited by this paper
• Spinal NF‐kB activation induces COX‐2 upregulation and contributes to inflammatory pain hypersensitivity

  2004cited by this paper
• Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.

  2004cited by this paper
• Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation.

  2004cited by this paper
• Interleukin-17 family members and inflammation.

  2004cited by this paper
• Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

  2004cited by this paper
• The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes.

  2003cited by this paper
• Targeting monocyte chemoattractant protein-1 signalling in disease

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

  2003cited by this paper
• The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.

  2002cited by this paper
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

  1999cited by this paper
• IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.

  1998cited by this paper
• Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines.

  1998cited by this paper
• Biologic basis for interleukin-1 in disease.

  1996cited by this paper
• T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

  1996cited by this paper
• Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

  1993cited by this paper
• Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB

  1993cited by this paper
• The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation

  year unknowncited by this paper

• Dual-targeting macromolecules: Bispecific antibodies as next-generation therapeutics for rheumatoid arthritis.

  2025cites this paper
• Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa

  2025cites this paper
• The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?

  2023cites this paper
• Mir204 and Mir211 suppress synovial inflammation and proliferation in rheumatoid arthritis by targeting Ssrp1

  2022cites this paper
• miR-223 in exosomes from bone marrow mesenchymal stem cells ameliorates rheumatoid arthritis via downregulation of NLRP3 expression in macrophages.

  2022cites this paper
• Sinomenine protects bone from destruction to ameliorate arthritis via activating p62Thr269/Ser272-Keap1-Nrf2 feedback loop.

  2021cites this paper
• RNA-seq reveals the circular RNA and miRNA expression profile of peripheral blood mononuclear cells in patients with rheumatoid arthritis

  2020cites this paper
• Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-κB pathway in collagen-induced arthritis rats

  2020cites this paper
• CypB-CD147 Signaling Is Involved in Crosstalk between Cartilage and FLS in Collagen-Induced Arthritis

  2020cites this paper
• Pain Mechanism in Rheumatoid Arthritis: From Cytokines to Central Sensitization

  2020cites this paper
• Dexamethasone-Loaded Thermosensitive Hydrogel Suppresses Inflammation and Pain in Collagen-Induced Arthritis Rats

  2020influential citation
• Regional Differences in the Gut Microbiota and Gut-Associated Immunologic Factors in the Ileum and Cecum of Rats With Collagen-Induced Arthritis

  2020cites this paper
• DDDT_A_256850 4101..4113

  2020influential citation
• Effect of astragalosides on long non-coding RNA expression profiles in rats with adjuvant-induced arthritis

  2019cites this paper
• Targeted therapy against hepatocellular carcinoma

  2019cites this paper
• Neutralization of Interleukin-17A Attenuates Lipopolysaccharide-Induced Mastitis by Inhibiting Neutrophil Infiltration and the Inflammatory Response

  2019cites this paper
• IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels

  2019cites this paper
• Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer's disease.

  2019cites this paper
• Transdermal delivery system of nanostructured lipid carriers loaded with Celastrol and Indomethacin: optimization, characterization and efficacy evaluation for rheumatoid arthritis

  2018influential citation
• Pain pathogenesis in rheumatoid arthritis—what have we learned from animal models?

  2018cites this paper
• IKKε aggravates inflammatory response via phosphorylation of ERK in rheumatoid arthritis

  2018cites this paper
• Dual Blockade of Interleukin-1β and Interleukin-17A Reduces Murine Arthritis Pathogenesis but Also Leads to Spontaneous Skin Infections in Nonhuman Primates

  2018cites this paper
• IKKε aggravates inflammatory response via activation of NF-κB in rheumatoid arthritis.

  2018cites this paper
• Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies.

  2018cites this paper
• Reconstruction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in rheumatoid arthritis.

  2017cites this paper
• Anhuienoside C Ameliorates Collagen-Induced Arthritis through Inhibition of MAPK and NF-κB Signaling Pathways

  2017cites this paper
• A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6

  2017cites this paper